HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cloudy Test Methods Behind Consumer Reports’ Sunscreen Complaints

This article was originally published in The Rose Sheet

Executive Summary

Of the 20 allegedly water-resistant, broad-spectrum sunscreens Consumer Reports tested, two provide the full SPF promised after subjects soaked in water, and two fell short of the critical wavelength required by FDA for products marketed as defending against UVB and UVA light. Industry trade groups contend the report is inaccurate and lacks crucial details about how tests were conducted.

You may also be interested in...



PCPC Scorches Consumer Reports Test Methods In Assessing SPF Claims

Consumer Reports says 11 of 34 sunscreens it tested fell short of SPF levels promised on product labels, according to the nonprofit. The Personal Care Products Council takes issue with CR’s testing methods, which deviated from FDA requirements for manufacturers.

PCPC Scorches Consumer Reports Test Methods In Assessing SPF Claims

Consumer Reports says 11 of 34 sunscreens it tested fell short of SPF levels promised on product labels, according to the nonprofit. The Personal Care Products Council takes issue with CR’s testing methods, which deviated from FDA requirements for manufacturers.

PCPC Blasts Consumer Reports' Test Methods For Assessing SPF Claims

Eleven of 34 sunscreens tested by Consumer Reports fell short of SPF levels promised on product labels, according to the nonprofit. The Personal Care Products Council takes issue with CR’s testing methods, which deviated from FDA requirements for manufacturers.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS019052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel